Analysis of Gastrointestinal Prophylaxis in Patients Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel

BACKGROUND: Dual antiplatelet therapy (DAPT) has been found to reduce the risk of cardiac death, myocardial infarction, stroke, and stent thrombosis following acute coronary syndrome and percutaneous coronary intervention. However, this therapy has also been shown to increase the risk of gastrointes...

Descripción completa

Detalles Bibliográficos
Autores principales: Morneau, Kathleen M., Reaves, Anne B., Martin, Julie B., Oliphant, Carrie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437942/
https://www.ncbi.nlm.nih.gov/pubmed/24456320
http://dx.doi.org/10.18553/jmcp.2014.20.2.187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437942/
https://www.ncbi.nlm.nih.gov/pubmed/24456320
http://dx.doi.org/10.18553/jmcp.2014.20.2.187

Ejemplares similares